Knee and other joint arthritis tissue therapy
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests a regenerative therapy made from a patient’s own fat tissue (a “cellular” treatment) to reduce pain and improve function in arthritis-related problems. It may help people with inflammatory or degenerative arthritis changes, if they meet safety and tissue-donation requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have arthritis-related wear-and-tear or inflammation in specific areas (often knee or hip, but also shoulder, Achilles tendon, sacroiliac joint, wrist/hand, foot/ankle, or plantar fasciitis)
- Your doctor feels you don’t have other major medical problems that would make the procedure unsafe for you
- You can understand the study and agree to the consent form
- You can provide enough donor tissue for the treatment (from around blood vessels and the tissue matrix, as directed by the study team)
- You are healthy enough to tolerate the procedure and complete follow-up visits and tracking
- You do not have key safety exclusions (like active infection or certain medications/conditions) as judged by the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a patient’s own (autologous) regenerative cell treatment to reduce knee pain and inflammation from osteoarthritis. It mainly looks at whether the treatment is safe and whether it can improve symptoms over time.
This trial tests a joint treatment made from your own platelets (platelet-rich plasma, or PRP) combined with other biologic material (from fat tissue and/or bone marrow) to help osteoarthritis symptoms. It may be an option if you have early-to-moderate osteoarthritis in a major joint and meet safety requirements.
This Phase 4 study tests whether injections made from body material—SVF or PRP—can reduce pain and improve function in people with knee osteoarthritis. You would be randomly assigned to one of the treatment approaches, and your knee would be monitored over the study.
This study tests whether a special injection of fat cells (MFAT) mixed with platelet-rich plasma (PRP) works better than either treatment alone for knee arthritis. It's for people with moderate to severe knee pain that hasn't improved with other treatments.
This trial tests an “autologous” regenerative cell treatment, meaning cells taken from you, to reduce hip osteoarthritis pain and inflammation. It checks safety first and looks for improvements in how you feel and move.
This Phase 2 study tests whether cells made from your own stored fat can improve osteoarthritis in your knee, hip, or shoulder. It’s for people who already have those fat-derived stem cells banked and who can safely follow the study plan.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.